Skip to main content
David Cohen, MD, Cardiology, Roslyn, NY

David J Cohen MD

Adult Congenital Heart Disease, Interventional Cardiology


Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine

Join to View Full Profile
  • 100 Port Washington BlvdSte 105Roslyn, NY 11576

  • Phone+1 516-390-9640

  • Fax+1 816-756-3645

Dr. Cohen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1989 - 1994
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
  • Harvard Medical School
    Harvard Medical SchoolClass of 1986

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2006 - 2026
  • MA State Medical License
    MA State Medical License 1989 - 2025
  • NY State Medical License
    NY State Medical License 2020 - 2025
  • KS State Medical License
    KS State Medical License 2006 - 2022
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Interventional Cardiology
    American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Journal Articles

  • Coronary Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights from the OPEN-CTO Re...  
    David J Cohen, Sophia Airhart, J Aaron Grantham, Adam C Salisbury, James M McCabe, John A Spertus, ScienceDirect
  • Original Investigation Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial  
    Eugene H Blackstone, Vinod H Thourani, Howard C Herrmann, David J Cohen, Martin B Leon, Michael J Mack, Raj R Makkar, Samir R Kapadia, Susheel K Kodali, Lars G Svensso..., ScienceDirect
  • Original Investigations Long-Term Survival Following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-on Study)  
    Michael Domanski, Samin K Sharma, David J Cohen, Valentin Fuster, George D Dangas, ScienceDirect
  • Join now to see all

Authored Content

  • Less Is Still More in Patients with Acute Myocardial Infarction and Cardiogenic ShockAugust 2018
  • Reply Cost-Effectiveness of Long-Term Ticagrelor in Patients with Prior Myocardial Infarction: Analysis by SubgroupsJanuary 2018

Press Mentions

  • Need for Rethink of Discharge Medications After LAA Closure? EMERGE
    Need for Rethink of Discharge Medications After LAA Closure? EMERGEMarch 12th, 2025
  • OPTION: LAAO Matches up to DOACs After Ablation, but Questions Remain
    OPTION: LAAO Matches up to DOACs After Ablation, but Questions RemainNovember 18th, 2024
  • ALIGN-AR at 2 Years Shows Promise for TAVI with Trilogy in Aortic Regurgitation
    ALIGN-AR at 2 Years Shows Promise for TAVI with Trilogy in Aortic RegurgitationOctober 29th, 2024
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: